Registration Tech Transfer Summit North America
Registration now open
The TTS North America (TTSNA) is the most important meeting globally for all those with a stake in biotechnology transfer, academia-industry partnering & collaboration, licensing and business development.
For university, institute and hospital tech transfer and commercialization officers, it is the most powerful platform available for networking and developing relationships and business with biotech and big pharma. The TTSNA delivers a more interactive and high-level mix of the most relevant industry licensing and business development executives than at any other meeting, in an atmosphere designed to foster interaction, discussion, debate and deliberation, business development and licensing. If your office will be at one meeting this year, it should be the TTS North America at the NIH.
For CEOs and business development directors from early stage Biotech Companies (SMEs) seeking to out-license or develop industry collaborations, the opportunities are far richer than in the usual company presentation events. The TTSNA is your best opportunity for real discussion and interaction with not only large biotech, big pharma and industry executives but also leading experts from legal, financial and VC backgrounds.
For biotech and pharma external R&D, licensing & business development executives, the TTSNA is the best platform available to meet early stage SMEs and the technology managers of the leading US research universities, institutes, clinics and hospitals, and ultimately, to develop the relationships needed with these “Gatekeepers to the Technology and Innovation” who are becoming more and more crucial in filling your strategic pipelines.
For serial entrepreneurs, source the best technologies and platforms for your next company and the most relevant VCs and industry executives.
For top level IP lawyers and service providers, the key opportunity to develop relationships with the leading technology innovators and the most important in-licensors.
For Governments and BioRegion directors, the TTSNA is the best place to learn what works and what does not in fostering biotech innovation and the development of a strong biotech sector, straight from the success and failures of the pioneering innovators of the sector.
Registrations are limited at the TTSNA, a high-level, interactive Summit and platform, one which no one with a serious stake in biotech innovation should miss.
What you get: Registration fees for the for the 2011 Tech Transfer Summit North America are kept to a minimum to ensure access for all key stakeholders, and include all of the following:
- Full access to the 2-day Tech Transfer Summit North America
- Access to the TTS Initiative Business Network for the TTS North America*
- Full access to all social events
- Coffee breaks, Lunches & Summit Reception
- Summit materials
*The TTS Initiative Business Network (Powered by JuJaMa) is more than just a partnering system. It is a powerful platform which enables you to post your profile, highlight your technology, licensing and IP offers, search other participants by name, category, interest, source and review licensing offers, and communicate not just during, but prior to and following the Summit, setting up meetings on or off-site with the key contacts you need to meet.
Places are limited to 450 attendees so register now!
Registration fees are:
- Academia, Start-up, Government: USD $549
- Industry, Legal, Financial, Advisory: USD $899
For information or assistance in registering for the TTS North America, please contact Andrea Gonzalez at the Summit Secretariat at MCI, and specify that you wish to register for the TTS North America:
ANDREA GONZALEZ
Tel: +34 91 400 93 84 | Fax: +34 91 504 37 74
TTS Ltd.
Sponsors & Partners:
